Publications by authors named "DeShaw M"

Introduction: Self injurious behaviour is not uncommon in depressed adolescents while little is known about effective treatments for this behaviour in this age group. The objective of this article is to illustrate the development and initial pilot of groups for adolescents who self injure and their parents.

Method: Articles and texts derived from a literature search of group treatments for self injuring adolescents were used to develop a pilot group for self injuring adolescents and a separate group for parents.

View Article and Find Full Text PDF

Background: The human immunodeficiency virus (HIV) epidemic in the US increasingly involves urban heterosexual adults, particularly women, belonging to ethnic minority groups. An understanding of gender-based differences in HIV risk behaviors within these groups would be of value in the ongoing struggle to limit HIV transmission in metropolitan centers.

Methods: This was a prospective study of demographic and historical characteristics and HIV risk behaviors.

View Article and Find Full Text PDF

We studied the rates of and factors associated with self-reported prior human immunodeficiency virus (HIV) testing in adult patients visiting an emergency department (ED) in the Bronx, New York City. A total of 1,744 consecutive noncritical adult medical emergency patients responded to a standardized interview administered by ED physicians. The interview included questions pertaining to demographic characteristics, prior HIV testing, and HIV risk behaviors.

View Article and Find Full Text PDF

Study Objective: To determine the prevalence of and risk factors associated with unrecognized HIV-1 infection among medical patients presenting to an inner-city emergency department.

Methods: We conducted anonymous HIV-1 testing in subjects interviewed for risk behaviors and knowledge of HIV status at an inner-city ED in the Bronx, New York. Our subjects were consecutive adult medical patients in noncritical condition (N = 1,744) who were evaluated by three physicians providing primary emergency care.

View Article and Find Full Text PDF

The Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan (GXM) has been conjugated to tetanus toxoid (GXM-TT) as an investigational vaccine. GXM-TT elicits antibodies that are protective in C. neoformans-infected mice.

View Article and Find Full Text PDF

Murine MoAbs to the Cryptococcus neoformans capsular glucuronoxylomannan (GXM) polysaccharide are protective in mice in vivo and in vitro. The prevalence of protective anti-GXM antibodies in human serum is unknown. To provide further insight into the human antibody response to C.

View Article and Find Full Text PDF

Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan (GXM) form the basis of two potential therapeutic intervention strategies, i.e., conjugate vaccines and passive antibody therapy.

View Article and Find Full Text PDF